David W. Stroman serves as Executive at NovaBay Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, David W. Stroman has executed 4 insider transactions totaling $37.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 12, 2014 involved purchasing 10,000 shares valued at $6.6K.
David W. Stroman currently holds 23,000 shares of NovaBay Pharmaceuticals, Inc. (NBY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David W. Stroman has been a net buyer of NBY stock. They have purchased $37.1K and sold $0 worth of shares.
David W. Stroman's most recent insider trade was on Dec 12, 2014, when they purchased 10,000 shares at $0.66 per share.
Get notified when new Form 4 filings are submitted
| $1.24 |
| Discretionary |
| Jun 16, 2011 | NBY | $10.1K | Purchase | 10,000 | $1.01 | Discretionary |
| Oct 25, 2007 | NBY | $8.0K | Purchase | 2,000 | $4.00 | Discretionary |